Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

750 results about "RNA Sequence" patented technology

RNA sequencing is the process of determining the sequence of nucleotides in a strand of ribonucleic acid, or RNA. RNA is composed of four nucleotides called adenine (A), guanine (G), cytosine (S), and uracil (S).

Spatial transcriptomics cell type deconvolution method based on generative adversarial network and comparative learning framework

The invention discloses a space transcriptomics cell type deconvolution method based on a generative adversarial network and a comparative learning framework. The method comprises the following steps: firstly, enhancing a gene expression matrix by using a histological image and spatial position information; then, in combination with GraphSAGE and self-supervised comparative learning, optimizing feature representation of space transcriptomics data, and reconstructing high-quality space gene expression data; single-cell RNA sequencing data gene expression features are extracted by using a variational automatic encoder, and meanwhile, the quality of a generated sample is optimized by using a discriminator, so that efficient feature extraction and accurate gene expression reconstruction are realized; and finally, mapping single-cell RNA sequencing data into spatial points through comparative learning and mapping matrix learning based on low-rank representation, thereby predicting the cell type of each point. According to the model, multi-modal information in single-cell RNA sequencing and space transcriptomics data is comprehensively considered, and a mapping matrix is constructed and optimized, so that the cell type of each space point is predicted.
Owner:QUFU NORMAL UNIV

Diagnostic marker of acute myelogenous leukemia prognosis model as well as application and prediction method thereof

The invention discloses a diagnostic marker of an acute myelogenous leukemia prognosis model as well as application and a prediction method of the diagnostic marker, and relates to the field of acute myelogenous leukemia prognosis research. The prognosis model is a prognosis model of acute myelogenous leukemia based on eight clinical characteristics, namely the disease age, the LDH level during disease, the RUNX1 gene, the KMT2A gene, the TP53 gene, the DMNT3A gene, the CBFB:: MYH11 gene and whether the first course of treatment is relieved or not; the construction method comprises the following steps of: sequentially carrying out univariate Cox regression analysis, Kaplan-Meier survival analysis and multivariate Cox regression analysis on clinical data of a patient from a data set and RNA sequencing data of peripheral blood and bone marrow samples in combination with survival information, further weighting an expression level according to an obtained regression coefficient, and carrying out quantitative analysis on the expression level. And establishing a prognosis model of acute myelogenous leukemia based on eight clinical characteristics. The acute myelogenous leukemia prognosis model disclosed by the invention has a relatively good evaluation effect.
Owner:ZHEJIANG UNIV

Chemically modified small nucleic acid drug zero sample prediction method and system based on large language model and multi-view deep learning

The invention relates to the technical field of biology, and discloses a chemically modified small nucleic acid drug zero sample prediction method and system based on a large language model and multi-view deep learning. The method comprises the following steps: collecting chemically modified RNA data; performing Token conversion by using an SMILES token regular expression, and performing embedding by using a pre-trained large language model; chemical modification position information is obtained and combined with SMILES in an embedded mode; the RNA sequence is embedded; processing the comprehensive embedded vector by using a self-attention mechanism; fusing RNA sequence embedding and comprehensive embedding by adopting a cross attention mechanism; performing feature extraction and dimension reduction by using a three-dimensional convolutional neural network; and inputting the features into a full-connection layer to predict the drug efficiency. According to the method, high-precision zero-sample prediction of novel chemical modification is realized, the generalization ability and prediction precision of the model are remarkably improved, and a flexible, efficient and accurate method is provided for design and development of RNAi drugs.
Owner:SHANGHAI EAST HOSPITAL EAST HOSPITAL TONGJI UNIV SCHOOL OF MEDICINE

UTR (Untranslated Region) element H2202 P1-G as well as construction method and application thereof

The invention provides an UTR (Untranslated Region) element H2202 P1-G as well as a construction method and application thereof, and relates to the technical field of mRNA (messenger ribonucleic acid). According to the present invention, the ribosome load prediction and the secondary structure optimization are performed on the natural 5 'UTR of the HIV TAT 202 gene through the BaidleHelix platform, and the obtained HTAT 202 P1 sequence avoids the inhibitory hairpin structure so as to significantly improve the luciferase expression quantity compared to the natural UTR; an ncRNA sequence without a secondary structure is introduced on the basis of the HTAT 202 P1, translation inhibition of a 5 'cap region is further relieved, and the protein expression quantity of the constructed H2202 P1-G mutant (the DNA sequence of the H2202 P1-G is as shown in SEQ NO 1, and the RNA sequence is as shown in SEQ NO 2) is further improved.
Owner:INST OF MEDICAL BIOLOGY CHINESE ACAD OF MEDICAL SCI

UTR (Untranslated Region) element NHP1 as well as construction method and application thereof

The invention provides an UTR element NHP1 as well as a construction method and application thereof, and relates to the technical field of mRNA. A 5 'UTR with a good expression effect is designed by integrating dominant sequences of a human high-expression gene and a pathogen natural UTR, a chimeric structure NHP1 with high ribosome load is predicted through a calculation model, a DNA sequence of the NHP1 is as shown in SEQ NO 1, and an RNA sequence of the NHP1 is as shown in SEQ NO 2; an EGFP report system is adopted on the DNA level to rapidly screen UTR; the translation efficiency is quantitatively evaluated on the RNA level through luciferase mRNA (N1-methyl pseudouridine modification); and the particle size is controlled by a microfluidic technology, so that the optimized UTR-mRNA is efficiently expressed after being delivered.
Owner:INST OF MEDICAL BIOLOGY CHINESE ACAD OF MEDICAL SCI

Spatial domain identification method based on data interpolation and cell type deconvolution

The invention provides a spatial domain identification method based on data interpolation and cell type deconvolution, and belongs to the technical field of bioinformatics. In order to solve the problems that gap information between adjacent points cannot be utilized in low-resolution spatial transcriptome data and prior information of cell types in a tissue space structure level cannot be fully integrated in a traditional method, the method comprises the following steps: acquiring a spatial transcriptome data set and a single-cell RNA sequencing data set, and performing data preprocessing on the acquired data sets; and carrying out data interpolation on the preprocessed spatial transcriptome data, and carrying out cell type deconvolution in combination with single-cell RNA sequencing data. And constructing a deep learning model based on the graph convolutional network. And training a deep learning model according to gene expression information, spatial position information and cell type information of the spatial transcriptome data after cell type deconvolution by using a self-supervised contrast learning strategy. And performing spatial domain identification on the to-be-detected data based on the trained model.
Owner:NORTHEAST FORESTRY UNIV

Methods and compositions for prime editing RNA

The present disclosure provides compositions and methods for the targeted modification of RNA molecules by RNA prime editing. The compositions and methods may be conducted invitro or in vivo within cells (e.g., human cells) for the therapeutic correction of disease-causing mutations and / or installation of motifs or mutations in RNA molecules of interest as a tool for scientific research. The disclosure provides compositions and methods for conducting RNA prime editing of a target RNA molecule (e.g., an RNA transcript) that enables the incorporation of one or more nucleotide changes and / or targeted mutagenesis of a target RNA molecule. The nucleotide change can include a single-nucleotide change, an insertion of one or more nucleotides, or a deletion of one or more nucleotides. More in particular, the disclosure provides a variety of configurations of the RNA prime editors each comprising a nucleic acid programmable RNA binding proteins (napRNAbp), such as Cas13, and an RNA-dependent RNA polymerase (RDRP), which are provided as fusion proteins or which can be separately provided in trans. The RNA prime editors are guided to a target RNA site by a guide RNA, which can be a rpegRNA that includes a template region for the synthesis of an RNA sequence to be installed on the RNA molecule attached to an available 3′ terminus. In others embodiments, the RNA template can be provided in trans.
Owner:THE BROAD INST INC +1

Full-length RNA sequencing

The present disclosure provides a method for analyzing a polyribonucleotide, wherein the polyribonucleotide is an mRNA molecule with a poly(A) tail, said method comprising: (a) obtaining a labeled polyribonucleotide by GI tailing; followed by (b) providing a second molecule comprising a first primer recognition sequence followed by a sequence of C nucleotide residues linked to a sequence of T nucleotide residues; followed by (c) obtaining a complex of said labeled polyribonucleotide and said second molecule; followed by (d) obtaining an extended second molecule by (d1) extending the 3′ end of the second molecule by synthesizing a sequence that is complementary to the labeled polyribonucleotide; followed by (d2) extending the 3′ end of the second molecule by adding at least 1 to 5 C nucleotide residues, followed by a second primer recognition sequence; said method providing information on entire polyribonucleotides, in particular mRNA isoforms and their respective poly(A) tails.
Owner:MAX DELBRUECK CENT FUER MOLEKULARE MEDIZIN

Twinborn clustering method and system for explaining single-cell RNA sequencing data

ActiveCN119068996Afast trainingThe clustering result is accurateBiostatisticsBiological modelsData setCell
The invention discloses a twinborn clustering method and system for explaining single-cell RNA sequencing data, and belongs to the technical field of biological information. The method comprises the following steps: preprocessing single-cell RNA sequencing data to obtain a preprocessed gene expression matrix, and constructing an intercellular K nearest neighbor graph based on the preprocessed gene expression matrix; performing feature space enhancement on the preprocessed gene expression matrix to obtain a disturbance attribute matrix # imgabs0 #, and performing structure space enhancement on the K nearest neighbor graph between the cells to obtain an enhanced graph; and performing information fusion and encoding and decoding based on the disturbance attribute matrix and the enhancement graph to obtain a clustering result corresponding to the single-cell RNA sequencing data. The scRNA-seq data clustering method can effectively solve the problems that an existing scRNA-seq data clustering method is insufficient in inter-cell information exploration, low in data anti-noise capacity and poor in large data set expandability.
Owner:COMP NETWORK INFORMATION CENT CHINESE ACADEMY OF SCI

Nucleic acid aptamer combined with TIDG6 protein as well as application and screening method of nucleic acid aptamer

The invention relates to the technical field of biology, in particular to a nucleic acid aptamer combined with TIDG6 protein, application and a screening method of the nucleic acid aptamer, and the nucleic acid aptamer has a nucleotide sequence as shown in SEQ ID NO.1; or a nucleotide sequence which has at least 30% homology with SEQ ID NO.1 and is combined with TIDG6 protein; the nucleic acid aptamer is an RNA sequence transcribed by a nucleotide sequence as shown in SEQ ID NO.1, or an RNA sequence transcribed by a nucleotide sequence as shown in SEQ ID NO.1. The nucleic acid aptamer is small in molecular weight, stable in chemical property, easy to store and mark, capable of being combined with TIDG6 protein with high affinity, very good in specificity, capable of being used in the aspects of detection, diagnosis, imaging, treatment and the like and wide in application prospect.
Owner:ZHEJIANG UNIV OF TECH +1

Single cell transcriptome data and text description conjoint analysis method based on multi-modal language model

The invention relates to the technical field of cell data analysis, and discloses a single-cell transcriptome data and text description conjoint analysis method based on a multi-modal language model, which comprises the following steps: acquiring a single-cell RNA sequencing expression matrix and a corresponding cell text description, preprocessing the single-cell RNA sequencing expression matrix and the corresponding cell text description, and analyzing the single-cell transcriptome data and the corresponding cell text description; according to the method, a multi-modal data set is constructed, deep fusion of gene expression data and text knowledge is realized by constructing a double-model and cross-modal projection module, limitation of a single mode is avoided, a gene expression value and an index sequence are reserved during preprocessing, a rough coding mode is changed, and the cell type identification accuracy is improved; based on a pre-training strategy of comparative learning, matching learning and a cross-modal projection module, fine-grained cross-modal information interaction and sharing are realized, and cross-modal task effects of text generation cells or cell generation texts and the like are optimized.
Owner:LONGYAN UNIV

RNA secondary structure prediction method and related device

The invention belongs to the field of data processing, and discloses an RNA secondary structure prediction method and a related device, and the method comprises the steps: converting an RNA sequence into a one-hot coding form, and carrying out the Kronecker inner product operation to obtain a first tensor; obtaining implicit pairing information between basic groups in the RNA sequence to obtain a second tensor; combining to obtain an input tensor, and calling a pre-trained DUMFold model to obtain a predicted contact matrix of the RNA sequence; optimizing the prediction contact matrix of the RNA sequence based on the physical constraint of the RNA structure to obtain a binary contact matrix of the RNA sequence; wherein according to the DUMFold model, each layer of the DUMFold model is set to be of a double-branch structure, and double-branch fusion is carried out by adopting a dynamic gating fusion mechanism; the first branch is a fully connected convolutional neural network; and the second branch comprises a visual state space module and a two-dimensional selective scanning module. An RNA secondary structure prediction model with good performance and strong universality is realized, and the secondary structure prediction accuracy of a long RNA sequence is improved.
Owner:XI AN JIAOTONG UNIV

Construction method for predicting RNA and small molecule binding site model based on RNA sequence and structure information characteristics and application of construction method

The invention discloses a construction method and application of a model for predicting binding sites of RNA and small molecules based on RNA sequence and structure information characteristics, and belongs to the technical field of biology. The construction method of the model comprises the following steps: S1, collecting modeling data; s2, dividing a data set; s3, dividing positive and negative data sets; s4, combining the RNA characteristics; and S5, constructing a model. The invention further provides a small molecule binding site prediction method based on RNA sequence and structure information. The prediction method is realized by adopting the model constructed by the method. The method has the beneficial effect that the efficiency and the accuracy of predicting the RNA-small molecule binding site are greatly improved. Experimental results on two independent test sets show that the overall performance of RNABind is superior to that of an existing method, and particularly, the call is greatly improved, so that the model can better capture a real sample. RNABind is expected to become a useful tool for designing RNA targeted small molecule drugs.
Owner:ANHUI UNIV

Methods and compositions for prime editing RNA

The present disclosure provides compositions and methods for the targeted modification of RNA molecules by RNA prime editing. The compositions and methods may be conducted invitro or in vivo within cells (e.g., human cells) for the therapeutic correction of disease-causing mutations and / or installation of motifs or mutations in RNA molecules of interest as a tool for scientific research. The disclosure provides compositions and methods for conducting RNA prime editing of a target RNA molecule (e.g., an RNA transcript) that enables the incorporation of one or more nucleotide changes and / or targeted mutagenesis of a target RNA molecule. The nucleotide change can include a single-nucleotide change, an insertion of one or more nucleotides, or a deletion of one or more nucleotides. More in particular, the disclosure provides a variety of configurations of the RNA prime editors each comprising a nucleic acid programmable RNA binding proteins (napRNAbp), such as Cas13, and an RNA-dependent RNA polymerase (RDRP), which are provided as fusion proteins or which can be separately provided in trans. The RNA prime editors are guided to a target RNA site by a guide RNA, which can be a rpegRNA that includes a template region for the synthesis of an RNA sequence to be installed on the RNA molecule attached to an available 3′ terminus. In others embodiments, the RNA template can be provided in trans.
Owner:THE BROAD INST INC +1

Single-cell RNA sequencing data classification method and system based on deep learning

The invention discloses a single-cell RNA sequencing data classification method and system based on deep learning. The invention provides a multi-scale neural network based on an improved Transform. The multi-scale neural network is used for classifying preprocessed single-cell RNA (Ribonucleic Acid) sequencing data. The multi-scale neural network integrates a multi-scale attention mechanism, relative position coding and a gating feedforward network, not only can the multi-level dependency relationship of data be captured, but also noise interference can be effectively reduced through feature screening. Compared with a traditional convolutional neural network or a classical Transform, the multi-scale neural network provided by the invention shows stronger robustness and generalization ability in sequence modeling and classification tasks. Through wide tests on a plurality of public data sets, the proposed multi-scale neural network shows better performance in a cell category classification task.
Owner:ZHEJIANG SCI-TECH UNIV

Cell differentiation trajectory inference method based on deep hyperbolic manifold embedding

The invention relates to a cell differentiation trajectory inference method based on deep hyperbolic manifold embedding. The method comprises the following steps: acquiring single-cell RNA sequencing data; introducing hyperbolic space embedding with negative curvature, performing feature extraction on the single-cell RNA sequencing data through a deep feature extraction network, and mapping extracted high-dimensional features to a low-dimensional hyperbolic space; through track inference in a low-dimensional hyperbolic space, transformation paths of cells from progenitor cells to various differentiation end cell types are constructed, and key genes and pathways are evaluated by utilizing a sensitivity analysis method. The method has the beneficial effects that by introducing hyperbolic space embedding with negative curvature, the model can better capture the hierarchical structure of data, and the accuracy and consistency of differentiation tracks are enhanced. Moreover, high-dimensional single-cell sequencing data can be processed, the limitation of a traditional method under the high-dimensional condition is overcome, and the applicability of the model is improved.
Owner:ZHEJIANG UNIV CITY COLLEGE

Method and system for predicting neoantigen of malignant solid tumor

The invention relates to the technical field of tumor neoantigen detection, and particularly discloses a neoantigen prediction method and system for a malignant solid tumor, and the method comprises the following steps: obtaining a tumor sample and a peripheral blood sample, and carrying out DNA and RNA sequencing; analyzing and processing to obtain DNA (Deoxyribonucleic Acid) sequencing data and RNA (Ribonucleic Acid) sequencing data; analyzing to obtain an HLA typing result and a sequence of the mutant protein; calculating to obtain related characteristic values of the new antigens; calculating a new antigen score; and intercepting the first N pieces with the highest scores to obtain a neoantigen prediction result of the malignant solid tumor. Starting from the action mechanism of the new antigens, according to key steps of the prediction process, a plurality of characteristic values are selected, a hard filtering index is not adopted, a product mode is adopted, and the score of the new antigens is calculated according to the score of the relevant characteristic values of the new antigens.
Owner:TIANJIN CANCER HOSPITAL AIRPORT HOSPITAL

Chemically modified single-stranded rna-editing oligonucleotides

The invention relates to antisense oligonucleotides that are capable of bringing about specific editing of a target nucleotide (adenosine) in a target RNA sequence in a eukaryotic cell, wherein said oligonucleotide does not, in itself, form an intramolecular hairpin or stem-loop structure, and wherein said oligonucleotide comprises a non-complementary nucleotide in a position opposite to the nucleotide to be edited in the target RNA sequence.
Owner:PROQR THERAPEUTICS II BV

Construction method of breast cancer lung metastasis prognosis prediction model

The invention relates to the technical field of medical informatics, and particularly discloses a construction method of a breast cancer lung metastasis prognosis prediction model. Comprising the following steps: (1) acquiring breast cancer in-situ and lung metastasis single cell RNA sequencing data by a GEO database, and preliminarily screening differential genes; (2) acquiring clinical information and gene expression profile information data of the breast cancer patient by a TCGA database, performing single-factor COX regression analysis, and screening genes related to the total survival rate; and (3) screening genes related to the total survival rate through LASSO regression to obtain six model genes, and calculating a risk scoring formula according to the expression quantity of the six model genes to complete the construction of the breast cancer pulmonary metastasis prognosis prediction model. According to the invention, scRNA-seq technical data from GSE202695 and a TCGA database are combined to develop a breast cancer lung metastasis prognosis prediction model based on six model gene characteristics of breast cancer lung metastasis.
Owner:SUN YAT SEN MEMORIAL HOSPITAL SUN YAT SEN UNIV

Knowledge-driven and data-driven magnaporthe oryzae AVR gene RNA secondary structure generator and prediction method thereof

ActiveCN119626339Aaccurate predictionfast executionBiostatisticsSequence analysisOriginal dataRna secondary structure prediction
The invention discloses a knowledge-driven and data-driven magnaporthe oryzae AVR (Automatic Voltage Regulation) gene RNA (Ribonucleic Acid) secondary structure generator, which is characterized in that an on-chip memory of an ARM (Advanced RISC Machines) chip and an external DRAM (Dynamic Random Access Memory) chip are adopted for respectively storing RNA original data and intermediate results; an FPGA chip is adopted to realize mapping from an RNA sequence to a knowledge graph, and features such as base pairing are fused through LUT; a multi-core AI chip is adopted, an encoder-decoder network is executed in parallel, and knowledge and data are fused to generate a secondary structure; and the VAE-GAN network is executed in a streamlined manner through an AI chip, the quality of the generated structure is evaluated and iteratively optimized, and an accurate RNA secondary structure is generated. The invention further discloses a knowledge-driven and data-driven fused magnaporthe oryzae AVR gene RNA secondary structure prediction method, RNA physicochemical characteristics are utilized, deep learning, transfer learning and knowledge distillation technologies are combined, and the prediction accuracy and operation efficiency are improved.
Owner:JILIN UNIVERSITY

Site-directed editing of RNA

The present disclosure, in some aspects, relates to antisense oligonucleotides (ASO) for use in the prevention or treatment of a disease or a condition associated with low- density lipoprotein (LDL) in a subject. In some embodiments, the ASO effects site-directed adenosine-to-inosine (A-to-l) editing of a target adenosine in a target RNA sequence derived from a sequence of an endogenous low-density lipoprotein receptor (LDLR) gene such that: a) the modified LDLR protein has: (i) reduced binding to the inducible degrader of the LDLR protein (IDOL); (ii) increased stability; (iii) improved resistance to IDOL-mediated degradation; (iv) increased LDLR protein expression; and / or (v) increased activity or function to take up LDL; and / or b) editing of the 3'-untranslated region (UTR) of the target RNA leads to an increase in LDLR protein expression and / or stability.
Owner:AIRNA CORPORATION +5

Method for predicting 2OM site in RNA (Ribonucleic Acid) based on ensemble learning

The invention discloses a method for predicting a 2OM site in RNA (Ribonucleic Acid) based on ensemble learning, and belongs to the technical field of bioinformatics. According to the method, specific task fine adjustment is carried out on the Promoter-BERT model according to the RNA sequence characteristics, so that the Promoter-BERT model can more effectively capture the complex mode of the RNA sequence in the specific task, and high-quality biological characteristic representation is obtained; the ANOVA technology is adopted to select extracted features, redundant features are removed, the most influential features are reserved, and in addition, the expression ability of the model is enhanced by combining traditional sequence features and embedded features obtained through a Word2Vec model; the prediction results of the lightweight gradient elevator and the deep learning model are combined, a final prediction model is formed through a soft voting mechanism, and the integration method not only improves the generalization ability of the model, but also improves the prediction stability.
Owner:ANHUI AGRICULTURAL UNIVERSITY

Reference model DRFORMER for RNA sequence downstream task

A reference model DRFORMER for downstream tasks of an RNA sequence comprises the following steps: S1, constructing 24-dimensional image visual features based on structural features, distance features and base pairing features of the RNA sequence; s2, pre-training the visual features of the image by using a SWIN model, and generating a visual reference model SWIN-RNA (Ribonucleic Acid); s3, the visual reference model SWIN-RNA is combined with an RNA sequence model, multi-modal feature fusion is achieved through a self-attention module and a cross attention module, and then a multi-modal reference model DRFORMER is constructed and used for RNA downstream task analysis. According to the scheme, the analysis and prediction performance of the reference model for downstream tasks can be improved.
Owner:HUZHOU UNIVERSITY

Prediction method for identifying RNA methylation sites

The invention discloses a method for predicting an RNA (Ribonucleic Acid) methylation site, which is based on a multi-modal feature fusion and semantic vector embedding technology and is used for remarkably improving the recognition precision of an m7G modification site. The method comprises the following steps: firstly, constructing an RNA sequence data set containing positive and negative samples, and dividing the RNA sequence data set into a training set and an independent test set according to a predetermined proportion; then, multi-modal features are extracted through One-hot coding (One-hot), nucleotide chemical property coding (NCP), electron-ion interaction potential coding (EIIP) and local nucleotide composition coding (ENAC), and context semantic information of a nucleotide sequence is obtained in combination with a DNA2Vec model; according to the model, a multi-modal feature fusion path (MRF) and a DNA2Vec embedding path are adopted, after feature dimension compression is carried out through a full connection layer, a Transform encoder is used for capturing a long-range dependency relationship, and a prediction probability is calculated through a Sigmoid activation function. In the optimization process, batch normalization, Dropout and Adam optimizers are adopted, and the binary cross entropy loss function is minimized. Finally, the performance of the model is evaluated through five-fold cross validation, and the generalization ability of the model is verified on an independent test set. According to the method, through multi-source feature fusion and hierarchical modeling, the analysis capability of sequence information is remarkably improved, and an accurate calculation tool is provided for RNA modification prediction.
Owner:GUILIN UNIV OF ELECTRONIC TECH

Predicting covid-19 antibodies among survivors with deep RNA sequencing

The invention provides a method for treating COVID-19 patients. Therapeutic antibodies of certain types of antibodies to COVID-19 are identified early by targeted diagnostic testing can be given to other COVID-19 patients to enhance their recovery. This invention also identifies bacterial pathogens, particularly those that are resistant to antibiotics, faster. Data from deep RNA sequencing of human blood is used to create a faster diagnostic test for infections and associated antimicrobial resistance. This invention thus also allows for appropriate antibiotic treatment at an earlier time point. The invention further provides improvements to RNA sequencing that can make RNA sequencing useful for diagnostic and therapeutic methods of treating sepsis. RNA sequencing can identify bacterial pathogens directly from the blood of patients with those infections.
Owner:RHODE ISLAND HOSPITAL

RNA sequence modification prediction model training method, prediction method and related device

The invention relates to a training method of an RNA sequence modification prediction model, a prediction method and a related device. The method comprises the following steps: acquiring modification site sequencing data of an RNA sequence; on the basis of sites with target chemical modification and sites without target chemical modification in the modification site sequencing data, a plurality of positive sample sequences with different lengths and a plurality of negative sample sequences with different basic groups added at the central position are obtained respectively, so that a multi-level classification database is constructed; inputting each sample sequence in the multi-level classification database into a to-be-trained modification prediction model to obtain a prediction result of a modification site of each sample sequence; and on the basis of the prediction result and the actual condition of each sample sequence, updating model parameters of the to-be-trained modification prediction model until the trained modification prediction model is obtained. Compared with the prior art, the method can improve the training efficiency and precision of the model.
Owner:PEKING UNIVERSITY CHENGDU ACADEMY FOR ADVANCED INTERDISCIPLINARY BIOTECHNOLOGIES +1

Single-cell multi-omics gene regulatory network reasoning method based on comparative learning

The invention discloses a single-cell multi-omics gene regulation network reasoning method based on comparative learning, and belongs to the technical field of biological information, and the method comprises the following steps: obtaining single-cell RNA sequencing data and single-cell chromatin accessibility data, and carrying out preprocessing to obtain a prior network of multi-omics data; loading the prior regulation and control network into a graph structure, and converting the graph structure into a feature space matrix; calculating a Pearson's correlation coefficient of two nodes on each side in the graph structure, when the Pearson's correlation coefficient is greater than a preset threshold value, taking the Pearson's correlation coefficient as a node pair, and storing the node pair and the corresponding feature vector and hidden vector into a data set; the data set is divided into a plurality of batches to be randomly input into the comparison learning model, and the node type of each node, the pairing degree of node pairs and node feature reconstruction vectors are obtained; and extracting the mapping of two nodes in the node feature reconstruction vector in the feature space by adopting a regulation and control network interpreter, and calculating the structural entropy of the nodes based on the mapping so as to determine whether the nodes are key nodes or not.
Owner:CHENGDU UNIV OF INFORMATION TECH +1

Single-cell drug sensitivity prediction algorithm based on multi-modal reinforcement learning

The invention provides a single-cell drug sensitivity prediction algorithm based on multi-modal reinforcement learning, and aims to solve the problem that the accuracy of a traditional drug sensitivity prediction method is limited. According to the system, multi-modal bioinformatics data including cell line gene expression data, proteome data, metabolome data, drug reaction data and single-cell RNA sequencing data are integrated, and feature extraction, fusion and selection are performed by using a deep reinforcement learning technology, so that high-precision prediction of single-cell drug sensitivity is realized. The algorithm mainly comprises five core modules: a multi-modal data integration and preprocessing module, a deep reinforcement learning feature extraction and fusion module, a dynamic feature selection and importance evaluation module, a cross-domain migration and adaptive learning module and a deep reinforcement learning prediction model and performance optimization module. The modules work cooperatively, potential features can be learned automatically from multi-modal data, a feature fusion strategy can be optimized, a key feature subset can be selected dynamically, and a model structure and parameters can be adjusted adaptively according to features of target domain data, so that prediction accuracy and stability are improved remarkably. Experimental results show that the algorithm shows significant advantages in multiple evaluation indexes, and compared with a traditional prediction method, the algorithm has higher prediction accuracy and wider applicability. Therefore, the invention provides a novel and efficient drug sensitivity prediction tool for the fields of personalized medical treatment and drug research and development, and has important practical application value.
Owner:NANJING TECH UNIV

RNA G-quadruplex prediction method and system based on pre-training model and RNA secondary structure

ActiveCN119724349ABiostatisticsBiological modelsPositive sampleHuman sequence
The invention discloses an RNA G-quadruplex prediction method and system based on a pre-training model and an RNA secondary structure, and the method comprises the steps: obtaining the position information of human rG4 on a human transcript; for each sequence, filling the same length to two sides according to the position coordinates of the sequence, so that the total length reaches a set length value; obtaining human cDNA sequence data as a reference sequence, and extracting rG4 data containing flanking sequence information from the cDNA sequence according to the filled sequence coordinates as a positive sample sequence; disorganizing each positive sample sequence to obtain a negative sample sequence; rNA secondary structure features of each sample sequence are generated; extracting sequence features of the sample sequence by using a pre-training model; and inputting the sequence features and the RNA secondary structure features into a prediction model for model training. According to the scheme, the secondary structural features of the RNA sequence are utilized, the secondary structural features are introduced as auxiliary information, and the prediction performance of the model can be remarkably improved.
Owner:YANGTZE DELTA REGION INST (QUZHOU) UNIV OF ELECTRONIC SCI & TECH OF CHINA

Methods and compositions for enrichment and sequencing of expansion-specific RNA transcripts

PCT designated stage expiredWO2024263649A1Microbiological testing/measurementDiseaseHybridization probe
Methods of isolating and sequencing aberrant expansion-specific RNA sequences using antisense oligonucleotides (ASO) specific for repeat-containing RNAs have been established. The methods isolate repeat-containing RNAs from RNA using hybridization probes specific for repeat-containing sequences. Typically, RNA capture is performed by preferential hybridization of repeat-containing RNAs to a multiplicity of immobilized probes. The methods isolate expansion-specific RNAs and determine the sequences of aberrant splice variants associated with diseases and disorders. In other forms, the methods identify small molecules that selectively target the pathological splice variant transcripts. In some forms, the methods provide expansion-specific ASOs that specifically target and eliminate the pathological splice variant transcripts in vivo. Compositions of ASOs that specifically target and eliminate the pathological splice variant transcripts are also provided.
Owner:YALE UNIVERSITY